Clinical significance of high-dose chemotherapy with autologous stem cell transplantation in the era of novel agents in patients older than 65 years with multiple myeloma

High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is the standard treatment for symptomatic multiple myeloma (MM) in patients under 65 years of age. However, the performing of ASCT in older patients > 65 years without comorbidities or complications is controversial. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Shuku, Tsunoda, Shun, Kawahigashi, Teiko, Kamata, Wataru, Tamai, Yotaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102120/
https://www.ncbi.nlm.nih.gov/pubmed/36951968
http://dx.doi.org/10.1007/s00277-023-05177-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102120/
https://www.ncbi.nlm.nih.gov/pubmed/36951968
http://dx.doi.org/10.1007/s00277-023-05177-7

Ejemplares similares